📰 Eric Rojas News
Page 2 - Eric Rojas News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Rojas. Real-time updates on events, politics, business and more.
September 5, 2023
– Data from multiple ongoing clinical studies of STK-001 show reductions in convulsive seizure frequency and improvements in cognition and behavior in children and adolescents with Dravet syndrome –– Data support the potential for STK-001 to be the first disease-modifying treatment for Dravet syndrome –– New pharmac...
August 9, 2023
50 Greatest Spanish-language Rappers of All Time
July 25, 2023
– Totality of data from these ongoing studies suggest clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modification –– Phase 1/2a ADMIRAL Study Data STK-001 (70mg): Patients treated with 2 or 3 ini...
July 6, 2023
No one had any idea what this might turn into. The very first Boilermaker Road Race was a nice thing, of course, a product of the running boom of the early 1970s.
June 17, 2023
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that, effective on June 15, 2023, the company granted stock options to purchas...
May 11, 2023
Marc Hunter's 1980 win shows the paradox of racing the Bolder Boulder most efficiently — and any long distance race — going out slower can make you faster.
May 4, 2023
- Data readout will focus on safety and seizure frequency results for up to 16 patients who received three doses of 45mg of STK-001 - - Company plans to initiate a pivotal study... | May 4, 2023
May 4, 2023
– Company on-track to report new data from the ongoing Phase 1/2a clinical studies of STK-001 in children and adolescents with Dravet syndrome in mid-2023 – – Data readout will focus on safety and seizure frequency results for up to 16 patients who received three doses of 45mg of STK-001 –– Company plans to initiate...
April 25, 2023
- Company advancing second TANGO ASO into the clinic - - STK-002 has the potential to be the first disease-modifying therapy to address the root cause of ADOA, the most common inherited optic nerve
April 21, 2023
This week a collaboration between Bad Bunny and Grupo Frontera, in addition to a historic chart placement for Mexican artist Peso Pluma, pushed regional Mexican music to international attention